Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases

被引：12
|
作者：
Stefan, Norbert [1 ,2 ]
Lonardo, Amedeo [3 ]
Targher, Giovanni [4 ,5 ]
机构：
[1] Univ Tubingen, Dept Internal Med 4, Div Endocrinol Diabetol & Nephrol, Tubingen, Germany
[2] Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis IDM, Tubingen, Germany
[3] Azienda Osped Univ Modena, Dept Internal Med, Modena, Italy
[4] Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy
[5] IRCCS Sacro Cuore Don Calabria Hosp, Metab Dis Res Unit, Verona, Italy
来源：
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2024年 / 21卷 / 03期
关键词：
D O I：
10.1038/s41575-023-00880-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Steatotic liver disease has emerged as an important risk factor for cardiovascular disease, type 2 diabetes mellitus and chronic kidney disease. Successful treatment of steatotic liver disease might also be effective in preventing these cardiometabolic diseases.
引用
收藏
页码：136 / 137
页数：2
相关论文
共 50 条
  • [31] Overlap prevalence and interaction effect of cardiometabolic risk factors for metabolic dysfunction-associated steatotic liver disease
    Zhao, Dongying
    Zheng, Xiaoyan
    Wang, Liwei
    Xie, Yujie
    Chen, Yan
    Zhang, Yongjun
    NUTRITION & METABOLISM, 2025, 22 (01)
  • [32] Willingness to participate in prevention programs for cardiometabolic diseases
    Jessica Petter
    Margreet M Reitsma-van Rooijen
    Joke C Korevaar
    Markus MJ Nielen
    BMC Public Health, 15
  • [33] The Role of RNA Splicing in Liver Function and Disease: A Focus on Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kaminska, Dorota
    GENES, 2024, 15 (09)
  • [34] Willingness to participate in prevention programs for cardiometabolic diseases
    Petter, Jessica
    Reitsma-van Rooijen, Margreet M.
    Korevaar, Joke C.
    Nielen, Markus M. J.
    BMC PUBLIC HEALTH, 2015, 15
  • [35] Prevention of cardiometabolic diseases through dietary modifications
    Chavez-Alfaro, Lourdes
    Silveira-Sanguino, Victor
    Piernas, Carmen
    CURRENT OPINION IN LIPIDOLOGY, 2025, 36 (01) : 14 - 20
  • [36] Cardiometabolic risk factors and coronary atherosclerosis progression in patients with metabolic dysfunction-associated steatotic liver disease: the influential role of quantity over type
    Kim, Aryoung
    Kang, Danbee
    Choi, Sung Chul
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2025, 40 (01) : 258 - 264
  • [37] Lipid droplets in steatotic liver disease
    Bilson, Josh
    Scorletti, Eleonora
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2024, 27 (02): : 91 - 97
  • [38] Crystalising the burden of steatotic liver disease
    Bertot, Luis Calzadilla
    Adams, Leon A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (10) : 1292 - 1293
  • [39] Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease
    Nakatsuka, Takuma
    Tateishi, Ryosuke
    Sato, Masaya
    Hashizume, Natsuka
    Kamada, Ami
    Nakano, Hiroki
    Kabeya, Yoshinori
    Yonezawa, Sho
    Irie, Rie
    Tsujikawa, Hanako
    Sumida, Yoshio
    Yoneda, Masashi
    Akuta, Norio
    Kawaguchi, Takumi
    Takahashi, Hirokazu
    Eguchi, Yuichiro
    Seko, Yuya
    Itoh, Yoshito
    Murakami, Eisuke
    Chayama, Kazuaki
    Taniai, Makiko
    Tokushige, Katsutoshi
    Okanoue, Takeshi
    Sakamoto, Michiie
    Fujishiro, Mitsuhiro
    Koike, Kazuhiko
    HEPATOLOGY, 2025, 81 (03) : 976 - 989
  • [40] LIVER-RELATED EVENTS AND MORTALITY IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE VARIES WITH THE TYPE OF CARDIOMETABOLIC RISK FACTOR
    Shalimar
    Biswas, Sagnik
    Elhence, Anshuman
    Gunjan, Deepak
    Gamanagatti, Shivanand
    HEPATOLOGY, 2024, 80 : S841 - S841
12345